AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glinix-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Saphnix Life Sciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glinix-M1 Tablet SR

Diabetol Duo SR tablets are a dual-action antidiabetic medication, prescribed for adult patients with type 2 diabetes. This combined formulation helps regulate blood glucose levels. Diabetol Duo SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headaches, and tremors, and know how to treat them promptly. Maintain regular mealtimes and carry a readily available fast-acting glucose source, like sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be minimized. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their doctor before commencing treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glinix-M1 Tablet SR

No information provided. Please provide the text you wish to be rewritten.

Uses of Glinix-M1 Tablet SR

Managing Type 2 diabetes

Major Benefits of Glinix-M1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glinix-M1 Tablet SR with a meal.

Common Side effects of Glinix-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glinix-M1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the Glinix-M1 Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be administered with food.

How Glinix-M1 Tablet SR works:

Glinix-M1 SR tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Glinix-M1 Tablet SR and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glinix-M1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glinix-M1 tablets are contraindicated for breastfeeding mothers due to the potential for infant toxicity.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glinix-M1 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glinix-M1 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. For those with mild to moderate liver disease, Glinix-M1 Tablet SR therapy typically begins with a low dose; however, it's contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Glinix-M1 Tablet SR :

Should you forget a Glinix-M1 Tablet SR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Glinix-M1 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glinix-M1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glinix-M1 Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Glinix-M1 Tablet SR and seek immediate medical attention.
Glinix-M1 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. Glinix-M1 SR is not suitable for treating type 1 DM.
Glinix-M1 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glinix-M1 Tablet SR use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 is recommended at least annually by some researchers.
Glinix-M1 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glinix-M1 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
Glinix-M1 Tablet SR
52
MRP 60
13% off